Anti-A Titre IgG Test in UAE | 130 AED | DHA Certified Immunohematology Assay

Executive Summary & Core Metrics

The Anti-A Titre IgG test delivers quantitative measurement of IgG antibodies against blood group A antigen using solid-phase Erythrocyte Magnetized Technology (EMT) at DNA Labs UAE. This ISO 9001:2015 certified assay provides ≤5% inter-assay variation with next-day reporting for samples received by 9 AM. Clinical applications include maternal-fetal ABO incompatibility monitoring, pre-transfusion antibody assessment, and hemolytic disease risk stratification. Direct DHA-licensed laboratory oversight under Facility License 1143 ensures full regulatory compliance across all UAE health authorities.

Test Overview & Methodology

The Anti-A IgG titre quantifies the concentration of immunoglobulin G antibodies directed against the A blood group antigen on red cell surfaces. This solid-phase assay uses erythrocyte magnetized technology to bind anti-A IgG from patient serum to magnetized A-positive red cell membranes, enabling precise endpoint titration through automated magnetic separation. Results are reported as the highest serum dilution that still produces visible agglutination, with critical clinical thresholds starting at a titre of 1:32 or higher during pregnancy surveillance.

Feature	DNA Labs UAE Anti-A IgG (EMT)	Standard Tube Agglutination
Methodology	Solid-phase Erythrocyte Magnetized Technology	Manual tube titration with anti-IgG
Precision (CV)	≤5% inter-assay variation	10–20% inter-observer variability
Turnaround Time	Next-day report (sample by 9 AM)	24–48 hours, often manual
Regulatory Status	ISO 9001:2015 certified, DHA/MOHAP compliant	May lack formal UAE accreditation

Physician Insight & Safety Protocols

Dr. Ajay Singh (General Practitioner, DHA Registration ID: 36234132): "An isolated Anti-A IgG titre must always be interpreted alongside the patient's complete clinical picture, including transfusion history, pregnancy status, and direct antiglobulin test results. A rising titre in pregnancy without appropriate clinical correlation can cause unnecessary anxiety, so I strongly advise discussing your results with your primary obstetrician or hematologist before any intervention. Timely monitoring of anti-A IgG titres in at-risk pregnancies provides critical data for neonatal care planning."

Advisory & Safety Considerations

Important Clinical Advisory

⚠️ Do not discontinue prescribed medication or alter your treatment plan without consulting your primary healthcare provider. Anti-A IgG titre results should be correlated with your full clinical history and managed by a qualified obstetrician or hematologist.

Exclusion Criteria & Emergency Red Flags

Collection not recommended during active hemolytic crisis.
If specimen shows gross hemolysis or lipemia, retesting on a new sample is mandatory.
Do not freeze sample; refrigerated transport must be maintained (2–8 °C) to preserve antibody integrity.
Seek emergency care immediately if you experience sudden jaundice, dark urine, severe back or flank pain, or shortness of breath – these may indicate a serious transfusion reaction or hemolysis.
This test is not a substitute for emergency blood bank consultation; for acute transfusion needs, contact your hospital's blood bank directly.

Patient FAQ & Clinical Guidance

1. What is the Anti-A IgG titre test used for?

A: The test detects and quantifies IgG antibodies against blood group A antigen that can cross the placenta and cause hemolytic disease of the newborn. It is routinely ordered during pregnancy in blood group O mothers carrying a group A fetus, and for pre-transfusion antibody screening in patients with a history of transfusion or pregnancy.

2. How should I interpret a titre result of 1:32?

A: A titre of 1:32 means the serum can still agglutinate group A red cells at a 32-fold dilution. In pregnancy monitoring, titres of 1:32 or higher are considered clinically significant and warrant close obstetric surveillance. Your managing physician will interpret this value in the context of your gestational age, previous pregnancies, and partner's blood group.

3. Do I need to prepare or fast before the blood draw?

A: No fasting or special preparation is required. Simply inform the phlebotomist about any recent blood transfusions, pregnancies, or immunizations. The sample is standard venous blood collected into a plain serum tube or gel separator tube.

4. Can this test be done from home through mobile phlebotomy?

A: Yes. Since the specimen is standard peripheral whole blood (serum/plasma), our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM. A trained phlebotomist will collect the sample at your residence or office under temperature-controlled cold-chain conditions to preserve specimen integrity.

5. When will I receive my results, and how are they delivered?

A: Results are reported the next business day if the sample is received by 9 AM. You will receive a secure digital report via WhatsApp or email, with a detailed interpretation including the measured titre value and clinical reference ranges.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates under DHA Facility License Number 1143 and adheres to the highest standards of patient data protection in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing, patient consent, and safety protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our ISO 9001:2015 certified laboratory ensures that your personal health information remains encrypted, access-controlled, and used exclusively for diagnostic purposes.

Clinical & Logistical Metadata

Test Name	Anti-A Titre IgG Test
Price (AED)	130 AED
Turnaround Time	Next day (samples received by 9 AM)
Sample Type / Matrix	Blood (Serum/Plasma) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM
Methodology Used	Solid-phase Erythrocyte Magnetized Technology (EMT)
ICD-10-CM Code	Z01.84 (Encounter for antibody response examination)
LOINC Code	2069-8 (Anti-A [Titer] in Serum or Plasma)
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE